ESSAI CLINIQUE
    No essai
    ClinicalTrials.gov ID
Coordonnateur(rice)
(EN) A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
    SGN35-015
    NCT01716806
     Actif en recrutement
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX  

Hodgkin (Maladie de) Olivier Cormier
514-252-3400 poste 5966